Back to search

Article

Lysosome-Dependent Sphingolipid Regulation as a potential therapeutic Target for Cohen Syndrome

2025-09-04

Abstract excerpt

<h4>ABSTRACT</h4> Cohen Syndrome (CS) is a rare autosomal recessive disorder caused by biallelic mutations in the VPS13B gene, affecting approximately 50,000 individuals worldwide. Clinical features include postnatal microcephaly, developmental delay, intellectual disability, neutropenia, and retinal dystrophy. VPS13B belongs to the bridge-like lipid transfer protein (BLTP) family, which also includes VPS13A, VP...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
545a5854-27c4-5548-932c-a6f3e2794d82
DOI
10.1101/2025.09.04.674037
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lysosome-Dependent Sphingolipid Regulation as a potential therapeutic Target for Cohen SyndromeDOI 10.1101/2025.09.04.674037
Select a neighboring publication to make it the new centre.